Vector-borne diseases are complex involving multiple components [pathogens, vectors, definitive or intermediate hosts, and the environment], which study requires a One Health approach and interdisciplinarity, contributing to the development of effective public health policies.
VBD Research Group aims to investigate the interaction between these components to develop evidence-based solutions that enhance control capacity.
Coordinator – Ana Paula Arez
Our objectives are:
- To characterize pathogen transmission dynamics across endemic regions and different settings to increase preparedness for described and new pathogen threats; arbovirus One Health Preparedness
- To investigate the dissemination and the underlying mechanisms of drug resistance within natural pathogen populations and search for novel therapeutic targets and drug candidates;
- To study vector bioecology, vectorial capacity and dispersion of insecticide resistance;
- To assess new candidates for insecticides and repellents, and implement alternative, ethical and sustainable tools for vector control based on manipulating vector’s physiology and competence;
- To monitor the influence of climate and environmental factors on the populations of vectors and intermediate hosts (reservoirs), and the diseases they transmit;
- To explore vector/host-pathogen interactions or the influence of the microbiome to uncover determinants, of individual susceptibility and resistance to infection and identify new agents for blocking transmission or infection.
-
- Differential Gene Expression of Malaria Parasite in Response to Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG)
- CRUZIVAX – Development of vaccines for Chagas disease
- Probing the rhipicephalus bursa sialomes in potential anti-tick vaccine candidates: A reverse vaccinology approach